Speaker illustration

Professor Nestor Galizio

Favaloro Foundation University Hospital, Buenos Aires (Argentina)

Secondary mitral regurgitation in heart failure. Benefit from cardiac resynchronization therapy at 12 and 24 months.

Event: EHRA 2019

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Cardiac Resynchronization Therapy

Thumbnail

Secondary mitral regurgitation in heart failure. Benefit from cardiac resynchronization therapy.

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Results (Resynchronization therapy)

Session: Cardiac resynchronisation therapy

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb